日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CDX2 confers ferroptosis resistance in stage II-III colon cancer via upregulation of NUPR1.

CDX2 通过上调 NUPR1 赋予 II-III 期结肠癌铁死亡抵抗力。

Yu Junhui, Mu Mingchao, Zhao Chenye, Li Xiaopeng, Ma Xueqian, Dong Zepeng, Sun Xuejun, Zheng Jianbao

FXR acts as a therapeutic target for ulcerative colitis via suppressing ferroptosis.

FXR 通过抑制铁死亡发挥治疗溃疡性结肠炎的作用

Zhao Chenye, Li Xiaopeng, Mu Mingchao, Quan Liyong, Yuan Hang, Zheng Jianbao, Zhao Wei, Sun Xuejun, Yu Junhui

ZIC5, a survival biomarker, facilitates tumor progression and stemness in colon cancer via the activation of the Wnt signaling pathway.

ZIC5 是一种生存生物标志物,它通过激活 Wnt 信号通路促进结肠癌的肿瘤进展和干细胞特性。

Li Xiaopeng, Zhao Chenye, Mu Mingchao, Yuan Hang, Chen Gang, Chen Shihui, Huo Xiongwei, Sun Xuejun, Yu Junhui

Clinical significance of the modified Naples prognostic score in patients with stage II-III colon cancer undergoing curative resection: a retrospective study from the real world

改良那不勒斯预后评分在接受根治性切除术的II-III期结肠癌患者中的临床意义:一项来自真实世界的回顾性研究

Li, Xiaopeng; Cheng, Chen; Huo, Xiongwei; Zhao, Chenye; Yuan, Hang; Chen, Gang; Yu, Junhui; Mu, Mingchao; Sun, Xuejun